AstraZeneca (AZN): Q2 EPS of $1.25 beats by $0.17. Revenue of $7.96B (+9%) vs. $7.58B. Sees...


AstraZeneca (AZN): Q2 EPS of $1.25 beats by $0.17. Revenue of $7.96B (+9%) vs. $7.58B. Sees full-year EPS of $4.60-4.90 vs. $4.46. Shares +3% in London. [PR (.pdf)]
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs